ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |